Iron Balance and its Disorders
Dr Allan Jacobs (Department ofHwamatology, CardiffRoyal Infirmary, Cardiff, CF2 ISZ) Availability and Absorption of Dietary Iron [Summary] There is no physiological control over the amount of iron lost from the body and the only method normally available for regulating the total body iron content is through the regulation of intestinal absorption. The upper jejunum is the major site of absorption though iron can be taken up at all levels of the gut, including the colon. The principal factors influencing absorption are those operating in the lumen of the intestine which determine availability of iron, intra-epithelial mechanisms regulating transit across the mucosa and changes within the body which signal iron requirements to the intestinal cells.
About 20-40% of the total iron in food is released by peptic digestion in the stomach and, with the exception of meat, most of this is in the form of ionizable inorganic iron (Jacobs & Greenman 1969) . In normal subjects the concentration of ionizable iron in the gastric contents after a meal reaches 100-300 ,ug/100 ml. In the absence of acid and pepsin, very little food iron is liberated; this is reflected by the low concentration of iron found in the stomachs of patients with achlorhydria following a test meal (Jacobs & Miles 1969) . When the gastric contents flow into the jejunum and partial neutralization occurs, ionized iron either binds with other substances present in the lumen or it precipitates. Iron-binding at this site can result in the formation of unavailable complexes (such as those with phytate and phosphate), it may produce complexes easily available for intestinal absorption (such as those with ascorbic acid and fructose) or it may form a macromolecular complex with gastric mucopolysaccharide. Evi-dence in vivo suggests that, under normal circumstances, most of the inorganic iron released from food in the stomach binds with gastric mucopolysaccharide. There is no good evidence that this substance acts either as an inhibitor or a potentiator of absorption but it seems likely that it acts as a carrier which enables iron to remain in solution at the neutral pH existing in the small intestinal lumen (Jacobs & Miles 1969) .
Hem iron released from food in the stomach appears to enter the intestinal epithelial cells unchanged, in the complex form. There is some evidence that the neutralization of gastric contents by pancreatic juice results in polymerization of hem, which reduces its availability unless other protein degradation products are also present to inhibit polymer formation (Conrad et al. 1967 ). The availability of haem iron is unaffected by gastric secretion. Once the hmm complex has entered the intestinal cell it is broken down and the iron released, at which point it probably joins the intracellular pathway followed by inorganic iron. Intraluminal factors in the gastrointestinal tract affect the availability of iron for uptake by epithelial cells but play no part in the physiological regulation of iron absorption.
The process of iron absorption is extremely sensitive to the iron requirements of the body. Subjects who are iron-deficient increase their absorption of iron whereas those with iron overload absorb relatively little. Iron which has entered the epithelial cell at the luminal pole appears to follow one of two possible pathways. It may be transported rapidly to the serosal pole and there transferred to the plasma or it may be converted to ferritin from which only a relatively small amount of iron is eventually transferred to plasma. Most of the mucosal ferritin is ultimately lost from the gut wall when the villous czlls are exfoliated. It is thought that the prime regulator of the amount of iron which is absorbed into the body via the 6 rapid transport pathway is the ability of the cell to synthesize ferritin and thus sequester the iron within the cell. Conrad et al. (1964) have shown that parenterally administered iron enters the intestinal mucosal cells from the serosal pole at the time of their emergence from the crypts of Lieberkuhn. It is suggested that in iron-deficient states relatively little iron enters the cells this way and ferritin formation is minimal, thus allowing any ingested iron to traverse the cell rapidly and be absorbed. In cases of iron overload the epithelial cells take up an increased amount of iron from the plasma, leading to increased ferritin synthesis and consequent sequestration of food iron in the cell, preventing its transfer to the plasma. Smith et al. (1968) have demonstrated mucosal ferritin synthesis in response to both enteral and parenteral administration of iron. If this interpretation is correct then it would be expected that the mucosal iron content would be inversely related to the amount of iron absorbed from a given dose. There is conflicting evidence on this point which some authors have attributed to methodological variation (Balcerzak & Greenberger 1968 ). Other authors have suggested that the control of iron absorption is by means of a humoral factor but this has not been identified (Conrad 1969 The main source of plasma iron is the breakdown of hemoglobin in the reticulo-endothelial system; small amounts of iron also come from the intestine and storage sites. Plasma iron is delivered to the marrow for heemoglobin synthesis and, in small amounts, to storage sites, mainly in the liver. During pregnancy there is also a considerable delivery to the placenta. All of this iron is carried by a single plasma protein, transferrin. Hiemo-globin synthesis requires 30-40 mg of iron each day, which is 6 to 10 times the total plasma iron. Transferrin is therefore vitally important in maintaining the supply of iron to the marrow for production of -normal red cells. Transferrin, or siderophilin as it is sometimes called, has a molecular weight of about 80,000 and can bind two atoms of ferric iron per molecule. The normal plasma iron is between 60 and 150 ,g/100 ml and represents about one-third of the plasma's total iron-binding capacity; that is, circulating transferrin is normally one-third saturated with iron.
Laurell (1951), who originally described transferrin, conceived of it as an iron carrier in the same way as hkmoglobin carries oxygen. This implies that, in sites where iron is released, there will be movement of free iron across a concentration gradient from the tissues to the plasma. Conversely, where iron is being utilized, the concentration gradient will be reversed and free iron released from transferrin. This concept became untenable when it was realized just how tightly iron is held by transferrin (Aasa et al. 1963 ). The binding is so firm that at the concentrations of iron and transferrin in the plasma there are no free iron atoms. This is not surprising as even tiny amounts of free iron are toxic. Instead, it seems that cells which require iron, in particular developing red cells, possess on or near their surfaces receptor sites which combine with transferrin molecules carrying iron (Jandl et al. 1959) . After attachment of the protein, there is either a change in its conformation or reduction of the carried iron to the ferrous state which allows iron to pass from transferrin to an intracellular carrier, which may be ferritin. The iron-free transferrin is displaced from the cell surface by the next transferrin molecule carrying iron. Thus, there is a plasma to cell to plasma cycle of transferrin which results in the efficient delivery of iron where it is required (Jandl & Katz 1963) . Free iron does not exist at any stage in the process. When hmemoglobin synthesis ceases the red cells lose their transferrin binding sites.
It is a basic assumption of many studies of iron metabolism that the plasma iron consists of a uniform pool. However, when iron is added to plasma in vitro, it combines at random at the two binding sites of transferrin to form a mixture of molecules carrying two, one or no iron atoms (Fletcher 1969) . The proportions of these molecules are determined by the level of saturation. At high saturation most molecules of transferrin carry two iron atoms, some carry one and almost none are iron-free. Consequently when iron is added to plasma at high saturation it combines mainly with molecules already carrying one iron atom to form saturated molecules and, if the added iron is radioactive, then these will be labell-
